How a new twice-yearly drug is prompting hopes of curbing HIV cases Podcast Por arte de portada

How a new twice-yearly drug is prompting hopes of curbing HIV cases

How a new twice-yearly drug is prompting hopes of curbing HIV cases

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

 The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But deep cuts to health initiatives could hinder the rollout. Lenacapavir not only offers nearly 100 percent protection from HIV, but people only need two injections per year. William Brangham discussed more with Mitchell Warren of the AIDS Vaccine Advocacy Coalition. PBS News is supported by - https://www.pbs.org/newshour/about/funders
Todavía no hay opiniones